Molecular Responses Are Observed across Mutational Spectrum in Treatment-Naïve Higher-Risk Myelodysplastic Syndrome Patients Treated with Venetoclax Plus Azacitidine
Garcia, Jacqueline S., Wei, Andrew H., Jacoby, Meagan A., Fong, Chun Yew, Borate, Uma, Baer, Maria R., Cunningham, Ilona, Odenike, Olatoyosi, Jurcic, Joseph G., Nowak, Daniel, Peterlin, Pierre, Platzbecker, Uwe, Dunshee, Diana, Zhou, Ying, Hoffman, David, Sun, Yan, Popovic, Relja, Ainsworth, Barrett, Naqvi, Kiran, Kye, Steve, Hogdal, Leah, Garcia-Manero, Guillermo
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Transcriptomics reveals in vivo efficacy of PARP inhibitor combinatorial synergy with platinum-based chemotherapy in human non-small cell lung carcinoma models
Stolzenburg, Lindsay R, Ainsworth, Barrett, Riley-Gillis, Bridget, Pakozdi, Tibor, Ammar, Areej, Ellis, Paul A, Wilsbacher, Julie L, Ramathal, Cyril Y
Published in Oncotarget (2022)
Published in Oncotarget (2022)
Get full text
Journal Article
Phase 1 study of vibecotamab identifies an optimized dose for treatment of relapsed/refractory acute myeloid leukemia
Ravandi, Farhad, Bashey, Asad, Foran, James, Stock, Wendy, Mawad, Raya, Short, Nicholas, Yilmaz, Musa, Kantarjian, Hagop, Odenike, Olatoyosi, Patel, Anand, Garcha, Raman, Ainsworth, William Barrett, Clynes, Raphael, Kanodia, Jitendra, Ding, Ying, Li, Huajiang, Kye, Steve, Mims, Alice
Published in Blood advances (14.11.2023)
Published in Blood advances (14.11.2023)
Get full text
Journal Article